CareDx, Inc

Filed a patent for "determining amounts of contributor-derived nucleic acids of a mixed sample (3+ genetically distinct genomic contributors) of a transplant recipient" on Fri, December 23, 2022

Filed a patent for "systems and methods for predicting transplant rejection" on Tue, July 5, 2022

Filed a patent for "systems and methods for vital asset transport" on Thu, December 28, 2023

Filed a patent for "methods for non-invasively monitoring organ health in cross-species transplantation" on Mon, March 21, 2022